Applied Therapeutics Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Applied Therapeutics, Inc. |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
APLT Q1 2025 10-Q filed. Financials look steady, focus on R&D.
AI Summary
Applied Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures related to its pharmaceutical preparations business are presented.
Why It Matters
This filing provides investors with the latest financial health and operational status of Applied Therapeutics, crucial for understanding its ongoing drug development and market position.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Applied Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 20250514 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Applied Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date of the 10-Q
- 2834 (dollar_amount) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Applied Therapeutics, Inc.?
Applied Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
For what period is this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What are some of the financial instruments or agreements mentioned in the filing?
The filing mentions Common Warrants, Pre-Funded Warrants, and specific offerings like PrivatePlacementApril2023 and June2022Offering.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Applied Therapeutics, Inc..